Voyageur Pharmaceuticals (CVE:VM) Reaches New 52-Week Low – Should You Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM) shares hit a new 52-week low on Monday . The stock traded as low as C$0.10 and last traded at C$0.10, with a volume of 59020 shares changing hands. The stock had previously closed at C$0.13.

Voyageur Pharmaceuticals Trading Down 23.1%

The stock’s 50 day simple moving average is C$0.15 and its 200 day simple moving average is C$0.16. The company has a debt-to-equity ratio of 2.77, a quick ratio of 0.84 and a current ratio of 0.58. The firm has a market cap of C$17.84 million, a PE ratio of -5.00 and a beta of 0.78.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.